Markus D.

Markus D. is an accomplished executive in the oncology research sector, currently serving as Executive Vice President and Head of Oncology at Evotec since April 2020, focusing on immuno-oncology and iPSC-based therapies. Previously, Markus held the role of Chief Scientific Officer at Achilles Therapeutics from February 2019 to March 2020, where leadership led to significant funding and clinical development milestones. At Medigene AG, from March 2016 to January 2019, Markus established a productive research team and transitioned TCR T cell projects into clinical development. Markus's extensive experience at Roche spanned several roles from May 2001 to March 2016, including Department Head, where management of a multidisciplinary oncology department was key, along with oversight of preclinical strategies and collaborations. Markus holds a Dr. degree in Biochemistry from Universität Innsbruck, earned between 1991 and 2001.